VHAQ vs. NOVN, NOVNQ, STAB, IGNY, AHPI, GNCA, HTGMQ, KLDO, HGEN, and PKBO
Should you be buying Viveon Health Acquisition stock or one of its competitors? The main competitors of Viveon Health Acquisition include Novan (NOVN), NVN Liquidation (NOVNQ), Statera Biopharma (STAB), Ignyte Acquisition (IGNY), Allied Healthcare Products (AHPI), Genocea Biosciences (GNCA), HTG Molecular Diagnostics (HTGMQ), Kaleido Biosciences (KLDO), Humanigen (HGEN), and Peak Bio (PKBO). These companies are all part of the "medical" sector.
Viveon Health Acquisition (NYSE:VHAQ) and Novan (NASDAQ:NOVN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.
Viveon Health Acquisition has a beta of -0.02, indicating that its share price is 102% less volatile than the S&P 500. Comparatively, Novan has a beta of -0.06, indicating that its share price is 106% less volatile than the S&P 500.
Novan received 239 more outperform votes than Viveon Health Acquisition when rated by MarketBeat users.
22.1% of Viveon Health Acquisition shares are held by institutional investors. Comparatively, 14.5% of Novan shares are held by institutional investors. 75.3% of Viveon Health Acquisition shares are held by company insiders. Comparatively, 1.3% of Novan shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Novan has a consensus price target of $8.00, suggesting a potential upside of 999,900.00%. Given Novan's higher probable upside, analysts plainly believe Novan is more favorable than Viveon Health Acquisition.
Viveon Health Acquisition has a net margin of 0.00% compared to Novan's net margin of -128.61%. Viveon Health Acquisition's return on equity of 0.00% beat Novan's return on equity.
Viveon Health Acquisition has higher earnings, but lower revenue than Novan.
In the previous week, Novan had 1 more articles in the media than Viveon Health Acquisition. MarketBeat recorded 1 mentions for Novan and 0 mentions for Viveon Health Acquisition. Viveon Health Acquisition's average media sentiment score of 0.00 equaled Novan'saverage media sentiment score.
Summary
Viveon Health Acquisition beats Novan on 7 of the 12 factors compared between the two stocks.
Get Viveon Health Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for VHAQ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VHAQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Viveon Health Acquisition Competitors List
Related Companies and Tools